Selective inner muscle layer myotomy is associated with lower pain and same clinical efficacy that full-thickness myotomy in patients treated by POEM for achalasia: a multicenter retrospective comparative analysis of 158 patients.

ACHALASIA OESOPHAGUS POEM SELECTIVE MYOTOMY

Journal

Clinics and research in hepatology and gastroenterology
ISSN: 2210-741X
Titre abrégé: Clin Res Hepatol Gastroenterol
Pays: France
ID NLM: 101553659

Informations de publication

Date de publication:
17 Jun 2024
Historique:
received: 24 01 2024
revised: 24 05 2024
accepted: 15 06 2024
medline: 20 6 2024
pubmed: 20 6 2024
entrez: 19 6 2024
Statut: aheadofprint

Résumé

The aim of this study was to compare the impact of the depth of myotomy (selective inner layer myotomy (SIM) vs. full-thickness myotomy (FTM)) on the outcome of patients treated with POEM for achalasia. This was a retrospective, observational, conducted in two tertiary centers between October 2018 and September 2022. Patients were divided into two groups: SIM and FTM. The primary endpoint was clinical efficacy at 6 months, while secondary endpoints were postoperative criteria (such as pain, length of hospital stay, complications) and occurrence of gastroesophageal reflux disease (GERD) (esophagitis at 6 months, heartburn, and pH-metry). 158 patients were included in the study (33 in the FTM group and 125 in the SIM group). The success rates at 6 and 12 months were similar in both groups, with 84% and 70% in the SIM group versus 90% and 80% in the FTM group, respectively (p=0.57 and p=0.74). However, more opioid analgesics were consumed in the FTM group compared to the SIM group (41% vs 21%, p<0.01). The length of hospitalization was longer in the FTM group than in the SIM group (2.17 ± 2.62 vs 2.94 ± 2.33, p<0.001). The rate of esophagitis at 6 months was comparable (16% in the SIM group vs 12% in the FTM group, p=0.73). There was no significant difference in terms of heartburn at 6 or 12 months between the SIM and FTM groups (18.5% vs 3.8%, p=0.07 and 27% vs 12.5%, p=0.35, respectively). There was no significant difference in terms of clinical efficacy and GERD occurrence between FTM and SIM. However, full-thickness myotomy was associated with more postoperative pain and a longer length of hospital stay. Therefore, selective internal myotomy should be preferred over full-thickness myotomy.

Identifiants

pubmed: 38897558
pii: S2210-7401(24)00122-0
doi: 10.1016/j.clinre.2024.102401
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102401

Informations de copyright

Copyright © 2024. Published by Elsevier Masson SAS.

Déclaration de conflit d'intérêts

Declaration of competing interest Drs. Mathilde Sanavio, Blandine Vauquelin, Marie-Christine Picot, Romain Altwegg, Anne Bozon, Flora Charpy, Ludovic Caillo, Arthur Berger, Frank Zerbib, Antoine Debourdeau have no conflicts of interest or financial ties to disclose.

Auteurs

Mathilde Sanavio (M)

CHU de Montpellier, Gastroenterology, Hepatology and Transplantation Department, Montpellier, Montpellier Univ, France. Electronic address: mathildesnv@gmail.com.

Blandine Vauquelin (B)

Gastroenterology and Hepatology Department, INSERM CIC 1401, Haut-Lévêque University Hospital, Bordeaux, France.

Marie-Christine Picot (MC)

Department of Medical Information, University Hospital of Montpellier, Montpellier Univ, France.

Romain Altwegg (R)

CHU de Montpellier, Gastroenterology, Hepatology and Transplantation Department, Montpellier, Montpellier Univ, France.

Anne Bozon (A)

CHU de Montpellier, Gastroenterology, Hepatology and Transplantation Department, Montpellier, Montpellier Univ, France.

Flora Charpy (F)

CHU de Montpellier, Gastroenterology, Hepatology and Transplantation Department, Montpellier, Montpellier Univ, France.

Ludovic Caillo (L)

CHU de Nimes, Gastroenterology and Hepatology Department, Nimes, Montpellier Univ France.

Arthur Berger (A)

Gastroenterology and Hepatology Department, INSERM CIC 1401, Haut-Lévêque University Hospital, Bordeaux, France.

Frank Zerbib (F)

Gastroenterology and Hepatology Department, INSERM CIC 1401, Haut-Lévêque University Hospital, Bordeaux, France.

Antoine Debourdeau (A)

CHU de Montpellier, Gastroenterology, Hepatology and Transplantation Department, Montpellier, Montpellier Univ, France; CHU de Nimes, Gastroenterology and Hepatology Department, Nimes, Montpellier Univ France.

Classifications MeSH